1. A phase 2 study of first‐line nivolumab in patients with locally advanced or metastatic cutaneous squamous‐cell carcinoma. Issue 24 (24th October 2022) Authors: Munhoz, Rodrigo R.; Nader‐Marta, Guilherme; de Camargo, Veridiana P.; Queiroz, Marcello M.; Cury‐Martins, Jade; Ricci, Hermínia; de Mattos, Marcela R.; de Menezes, Thiago A. F.; Machado, Guilherme U. C.; Bertolli, Eduardo; Barros, Milton; de Souza, Carina E.; Franke, Fábio; Ferreira, Fabio O.; Fe... Journal: Cancer Issue: Volume 128:Issue 24(2022) Page Start: 4223 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinicopathological and molecular profile of grade 3 gastroenteropancreatic neuroendocrine neoplasms. (16th February 2022) Authors: Taboada, Rodrigo; Claro, Laura; Felismino, Tiago; de Jesus, Victor Hugo; Barros, Milton; Riechelmann, Rachel P. Journal: Journal of neuroendocrinology Issue: Volume 34:Number 4(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Everolimus-Induced Pneumonitis in Patients with Neuroendocrine Neoplasms: Real-World Study on Risk Factors and Outcomes. (1st February 2022) Authors: Taboada, Rodrigo G; Riechelmann, Rachel P; Mauro, Carine; Barros, Milton; Hubner, Richard A; McNamara, Mairéad G; Lamarca, Angela; Valle, Juan W Journal: Oncologist Issue: Volume 27:Number 2(2022) Page Start: 97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗